These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 3627626
1. Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974-1984. Jones WB, Koulos JP, Saigo PE, Lewis JL. Obstet Gynecol; 1987 Oct; 70(4):573-7. PubMed ID: 3627626 [Abstract] [Full Text] [Related]
2. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma. Blythe JG, Michael H, Hodel KA. J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354 [Abstract] [Full Text] [Related]
6. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma. Edelman DA. Int J Fertil; 1989 Feb; 34(4):251-5. PubMed ID: 2570761 [Abstract] [Full Text] [Related]
7. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. Melnick S, Cole P, Anderson D, Herbst A. N Engl J Med; 1987 Feb 26; 316(9):514-6. PubMed ID: 3807995 [Abstract] [Full Text] [Related]
8. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals. Clin Pediatr (Phila); 1983 Feb 26; 22(2):139-43. PubMed ID: 6822019 [Abstract] [Full Text] [Related]
9. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina. Hill EC. Trans Pac Coast Obstet Gynecol Soc; 1972 Feb 26; 40():15-29. PubMed ID: 4668177 [No Abstract] [Full Text] [Related]
11. The surgical management of invasive cancer of the cervix in pregnancy. Thompson JD, Caputo TA, Franklin EW, Dale E. Am J Obstet Gynecol; 1975 Mar 15; 121(6):853-63. PubMed ID: 1119493 [Abstract] [Full Text] [Related]
14. Development of clear cell adenocarcinoma in DES-exposed offspring under observation. Kaufman RH, Korhonen MO, Strama T, Adam E, Kaplan A. Obstet Gynecol; 1982 Jun 15; 59(6 Suppl):68S-72S. PubMed ID: 7088431 [Abstract] [Full Text] [Related]
15. Diethylstilbestrol-related clear-cell adenocarcinoma in women with initial examinations demonstrating no malignant disease. Kramer MS, Seltzer V, Krumholz B, Talebian F, Tedeschi C, Chen S. Obstet Gynecol; 1987 Jun 15; 69(6):868-71. PubMed ID: 3574818 [Abstract] [Full Text] [Related]
16. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Adam E, Decker DG, Herbst AL, Noller KL, Tilley BC, Townsend DE. Cancer Res; 1977 Apr 15; 37(4):1249-51. PubMed ID: 844051 [No Abstract] [Full Text] [Related]
17. The effects in the human of diethylstilbestrol (DES) use during pregnancy. Herbst AL. Princess Takamatsu Symp; 1987 Apr 15; 18():67-75. PubMed ID: 3506546 [Abstract] [Full Text] [Related]
19. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic. Piver MS, Lele SB, Baker TR, Sandecki A. Cancer Detect Prev; 1988 Apr 15; 11(3-6):197-202. PubMed ID: 3390844 [Abstract] [Full Text] [Related]
20. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol]. Schreiner WE, Bronz L, Wyss-Bernet M, Genton CY. Schweiz Med Wochenschr; 1985 Nov 02; 115(44):1555-61. PubMed ID: 3841230 [Abstract] [Full Text] [Related] Page: [Next] [New Search]